home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

New Class Of Stem Cells May Pave The Way For Therapies

 
  June, 17 2003 4:47
your information resource in human molecular genetics
 
     
In the July issue of Nature Medicine, Canadian researchers describe a novel class of human stem cells that can rapidly generate blood cells. The results may help develop new human cell-based therapies.

Hematopoietic stem cells (HSCs) reside in the bone marrow and replenish the body’s supply of blood cells. John Dick and colleagues injected human cord blood cells into the bone marrow - rather than into the bloodstream - of mice. Different classes of human blood cells quickly grew from a previously undescribed class of HSCs, the researchers found.

Transplanting cord blood into the bone marrow is an efficient method to identify and characterize stem cells, the researchers conclude. Their study also promises to further knowledge about human stem cells, which are currently much less understood than mouse stem cells.

Author contact:

John Edgar Dick
University of Toronto
Ontario, Canada
Tel: + 1 416 946 6549
E-mail: jdick@uhnres.utoronto.ca

Also available online.

(C) Nature Medicine press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.